Malignant Pericardial Diseases

Diagnosis and Treatment
  • Jeffrey Kralstein
  • William Frishman

Abstract

Pericardial aspects of malignant disease can encompass numerous clinical entities, which may include asymptomatic chronic pericardial effusions, constrictive pericarditis, effusive constrictive pericarditis, or pericardial tamponade. A high index of suspicion is necessary to recognize the various aspects of malignant pericardial disease, since their occurrence is more frequent than is commonly appreciated. It is the purpose of this chapter to review the incidence and etiology, mechanism, clinical presentation, and therapeutic modalities available to the oncologist in diagnosing and treating malignant disease.

Keywords

Malignant Mesothelioma Cardiac Tamponade Catheter Drainage Mycosis Fungoides Constrictive Pericarditis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Scott RW, Garvin CF: Tumors of the heart and pericardium. Am Heart J 17: 431–46, 1939.CrossRefGoogle Scholar
  2. 2.
    Glancy DL, Roberts WC: The heart in malignant melanoma: A study of 70 autopsy cases. Am J Cardiol 21: 555–71, 1968.PubMedCrossRefGoogle Scholar
  3. 3.
    Roberts WC, Glancy DL, De Vita VT: Heart in malignant lymphoma (Hodgkin’s disease, lymphosarcoma, reticulum cell sarcoma and mycosis fungoides): A study of 196 autopsy cases. Am J Cardiol 22: 85–107, 1968.PubMedCrossRefGoogle Scholar
  4. 4.
    Roberts WC, Bouley GP, Wertlake PT: The heart in acute leukemia: A study of 420 autopsy cases. Am J Cardiol 21: 388–411, 1968.PubMedCrossRefGoogle Scholar
  5. 5.
    Thurber DL, Edwards JE, Achor RW: Secondary malignant tumors of the pericardium. Circulation 26: 228–41, 1962.PubMedCrossRefGoogle Scholar
  6. 6.
    DeLoach JF, Haynes JW: Secondary tumors of the heart and pericardium. Arch Intern Med 91: 224–228, 1953.CrossRefGoogle Scholar
  7. 7.
    Kline JK: Cardiac lymphatic involvement by metastatic tumor. Cancer 29: 799–808, 1972.PubMedCrossRefGoogle Scholar
  8. 8.
    Posner MR, Cohen GI, Skasin AT: Pericardial disease in patients with cancer. Am J Med 71: 407–413, 1981.PubMedCrossRefGoogle Scholar
  9. 9.
    Fraser RS, Viloria JB, Wang NS: Cardiac tamponade as a presentation of extracardiac malignancy. Cancer 45: 1697–1704, 1980.PubMedCrossRefGoogle Scholar
  10. 10.
    Wong B, Murphy J, Chang CJ, et al: The risk of pericardiocentesis: Outlines of failure factors associated with success when pericardiocentesis is attempted. Am J Cardiol 44: 1110–1114, 1979.PubMedCrossRefGoogle Scholar
  11. 11.
    Smith FE, Lane M, Hodgins DT: Conservative management of malignant pericardial effusion. Cancer 33: 147–152, 1974.CrossRefGoogle Scholar
  12. 12.
    Davis S, Sharma SM, Blumberg ED, Kim CS: Intrapericardial tetracycline for the management of cardiac tamponade secondary to malignant pericardial effusion. N Engl J Med 229: 1113–1114, 1978.CrossRefGoogle Scholar
  13. 13.
    Cham WC, Freeman AH, Carsten PHB: Radiation therapy of cardiac and pericardial metastases. Ther Radiol 114: 701–705, 1975.Google Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • Jeffrey Kralstein
    • 1
  • William Frishman
    • 2
  1. 1.Albert Einstein College of Medicine; Department of MedicineBronx Municipal Hospital CenterBronxUSA
  2. 2.Albert Einstein College of Medicine; Medical ServiceWeiler-Einstein College HospitalBronxUSA

Personalised recommendations